Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05100563 · ClinicalTrials.gov registry record
Participant(s) With Autism and High Pain Tolerance Treated With High Dose Naltrexone
A clinical trial, sponsored by State University of New York - Upstate Medical University.
- Completed
- Registry status
- 1
- Enrollment target
NCT05100563 is a clinical trial that has completed, run by State University of New York - Upstate Medical University. The registered enrollment target is 1 participants.
The verdict
NCT05100563 has completed, sponsored by State University of New York - Upstate Medical University.
- COMPLETED
- Registry status
- 1 participants
- Enrollment target
Study Summary
High dose naltrexone with response gauged by pain tolerance as measured by the cold pressor test may help treat autism.
Interventions
- DRUG 50 mg naltrexone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2021-05-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05100563
The ClinicalTrials.gov registry entry for NCT05100563 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Upstate Medical University, which has 113 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 50 mg naltrexone is the first listed.
NCT05100563 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05100563 about?
NCT05100563 is a clinical study titled "Participant(s) With Autism and High Pain Tolerance Treated With High Dose Naltrexone". High dose naltrexone with response gauged by pain tolerance as measured by the cold pressor test may help treat autism.
What is the current status of trial NCT05100563?
This trial is currently completed. The enrollment target is 1 participants. The study started on 2018-10-01. Estimated completion is 2021-05-24.
What interventions are being tested in trial NCT05100563?
The interventions under investigation include: 50 mg naltrexone (DRUG).
Who is sponsoring clinical trial NCT05100563?
This trial is sponsored by State University of New York - Upstate Medical University, which has 113 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.